GREM1 has been suggested to be a modulator of mesangial cell proliferation and epithelial–mesenchymal transdifferentiation in diabetes and has been shown to have increased expression in various diabetic nephropathy models as well as being involved in the pathophysiology of progressive renal fibrogenetic diseases [26, 27]. The gene discussed is GREM1; the disease is diabetic kidney disease.